AlzChem Group AG (FRA:ACT) Debt-to-Equity : 0.39 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is AlzChem Group AG Debt-to-Equity?

AlzChem Group AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €10.4 Mil. AlzChem Group AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €52.0 Mil. AlzChem Group AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €161.6 Mil. AlzChem Group AG's debt to equity for the quarter that ended in Dec. 2023 was 0.39.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for AlzChem Group AG's Debt-to-Equity or its related term are showing as below:

FRA:ACT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.39 Med: 0.75 Max: 1.21
Current: 0.39

During the past 13 years, the highest Debt-to-Equity Ratio of AlzChem Group AG was 1.21. The lowest was 0.39. And the median was 0.75.

FRA:ACT's Debt-to-Equity is ranked worse than
54.19% of 1397 companies
in the Chemicals industry
Industry Median: 0.35 vs FRA:ACT: 0.39

AlzChem Group AG Debt-to-Equity Historical Data

The historical data trend for AlzChem Group AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AlzChem Group AG Debt-to-Equity Chart

AlzChem Group AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

1.21

1.03

0.64

0.70

0.39

AlzChem Group AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.70	-	0.55	-	0.39

Competitive Comparison of AlzChem Group AG's Debt-to-Equity

For the Specialty Chemicals subindustry, AlzChem Group AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AlzChem Group AG's Debt-to-Equity Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, AlzChem Group AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where AlzChem Group AG's Debt-to-Equity falls into.

AlzChem Group AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

AlzChem Group AG's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(10.446	+	52.042)	/	161.625
	=	0.39

AlzChem Group AG's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(10.446	+	52.042)	/	161.625
	=	0.39

AlzChem Group AG (FRA:ACT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

AlzChem Group AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of AlzChem Group AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AlzChem Group AG (FRA:ACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » AlzChem Group AG (FRA:ACT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

ACT:Germany

Address

Dr.-Albert-Frank-Street 32, Trostberg, DEU, 83308

Website

https://www.alzchem.com

AlzChem Group AG is an international chemical company. Its reportable segments are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from Germany.